tiprankstipranks
TipRanksTop Financial ExpertsInsidersMark Enyedy

Mark Enyedy Insider Profile

4 Followers
Mark Enyedy, Director at BioMarin Pharmaceutical, holds 21.04K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 2.38K shares in Charles River Labs (Ticker: CRL), holds 0.00 shares in ImmunoGen (Ticker: IMGN).
See the Hottest Stocks Based on Insider Trading >
tipranks
Mark Enyedy

Mark Enyedy
BioMarin Pharmaceutical (BMRN)
Director

Not Ranked
Mark Enyedy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$2M
65.27%
31.33%
1.99%
1.40%
0.00% Others
A breakdown of Mark Enyedy's holdings
See the Top Stocks by Insiders

Insider Roles

BioMarin Pharmaceutical
(BMRN)
Director
Charles River Labs
(CRL)
Director
ContextLogic Holdings
(LOGC)
Director
Akebia Therapeutics
(AKBA)
Director
+1 other positions
Roles that Mark Enyedy holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Mark Enyedy
See the Latest Stocks Traded by Insiders

Mark Enyedy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BMRN
BioMarin Pharmaceutical
Jun 04, 2026
Director
Uninformative Buy
―
$1.38M
LOGC
ContextLogic Holdings
Jan 04, 2021
Director
Uninformative Buy
53.28K
$42.21K
CRL
Charles River Labs
May 11, 2026
Director
Uninformative Buy
255.42K
$663.37K
FATE
Fate Therapeutics
―
Director
―
$0.00
IMGN
ImmunoGen
Feb 12, 2024
―
Uninformative Sell
―
$0.00
KERX
Keryx Biopharma
Dec 13, 2018
―
Uninformative Sell
―
$0.00
AKBA
Akebia Therapeutics
Jun 09, 2020
Director
Uninformative Buy
―
$29.62K
~LOGC
Logicbio Therapeutics
Nov 17, 2022
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Mark Enyedy's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Mark Enyedy insider profile FAQ

What is the percentage of profitable transactions made by Mark Enyedy?
The percentage of profitable transactions made by Mark Enyedy is ―.
    What is the average return per transaction made by Mark Enyedy?
    The average return per transaction made by Mark Enyedy is ―.
      What stocks does Mark Enyedy hold?
      Mark Enyedy holds: BMRN, LOGC, CRL, FATE, IMGN, KERX, AKBA, ~LOGC stocks.
        What was Mark Enyedy’s latest transaction?
        Mark Enyedy latest transaction was an Uninformative Buy of ―.
          What was Mark Enyedy's most profitable transaction?
          Mark Enyedy’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Mark Enyedy's role in BioMarin Pharmaceutical?
            Mark Enyedy's role in BioMarin Pharmaceutical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.